Ben Lamm
Ben Lamm is the co-founder and CEO of Colossal Biosciences, a company he established in July 2021. As a serial entrepreneur, Lamm has been instrumental in pioneering de-extinction and conservation biology efforts at Colossal, leveraging advanced genetic engineering and CRISPR technology. His leadership has positioned Colossal at the forefront of biotechnology innovation, aiming to make a substantial impact on biodiversity and conservation. Ben Lamm co-founded Colossal Biosciences in 2021, pioneering de-extinction and conservation efforts, notably with the woolly mammoth project. Prior to this, he founded Hypergiant in 2018, an enterprise AI company, and led Chaotic Moon Studios (acquired by Accenture in 2015) and Conversable (acquired by LivePerson in 2018). Lamm's career demonstrates a consistent ability to build and scale innovative technology companies. His current work at Colossal Biosciences leverages these entrepreneurial successes to address critical global challenges in biodiversity and conservation.
About Colossal Biosciences
Colossal Biosciences, founded in 2021, is a biotechnology and genetic engineering company. They aim to de-extinct species like the woolly mammoth, Tasmanian tiger, and dodo to restore ecosystems and advance conservation. Their core features include advanced gene editing (CRISPR), computational genomics, and reproductive technologies. Benefits extend to biodiversity, ecosystem health, and potential human healthcare applications.